Table 4.
Outcome domain | Number (%)of RCD trials, n = 101 | Number (%)of AC trials, n = 51 | Risk ratioa (95% CI) |
---|---|---|---|
Pain | 92 (91) | 39 (76) | 1.2 (1.01–1.4) |
Function/disability | 75 (74) | 34 (67) | 1.1 (0.9–1.4) |
Adverse events | 29 (29) | 13 (25) | 1.1 (0.6–2.0) |
Global assessment of treatment success | 21 (21) | 9 (18) | 1.2 (0.6–2.4) |
Range of movement | 59 (58) | 42 (82) | 0.7 (0.6–0.9) |
Strength | 26 (26) | 1 (2) | 13.1 (1.8–94.0) |
Health-related quality of life | 18 (18) | 7 (14) | 1.3 (0.6–2.9) |
Work disability | 7 (7) | 0 | 8.2 (0.5–146.0)b |
Referral for surgery | 4 (4) | 0 | 4.8 (0.3–90.0)b |
Abbreviations: RCD, rotator cuff disease; AC, adhesive capsulitis.
Note that 19 trials including participants with nonspecific shoulder pain were excluded from the previously mentioned analysis.
Risk ratio, risk of outcome reported in RCD trials/risk of outcome reported in AC trials.
Odds ratios calculated from penalized likelihood logistic regression.